Von Hippel–Lindau (VHL) is a tumor suppressor that leads to the ubiquitination and destruction of hypoxia-inducible factor (HIF)1α and HIF2α (HIF1/2α) in normoxic conditions and is mutated in 64% of ccRCC cases [121]. Here, HIF1A is linked to nonpapillary renal cell carcinoma.